Description: Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty pharmaceuticals for use in the field of rheumatology and dermatology in the People's Republic of China and internationally. The company operates through Pharmaceuticals, Cosmetics Products, and Healthcare Products segments. It offers Chinese medicine generic drugs; cosmetic products; and healthcare products. The company was founded in 2001 and is headquartered in Ningbo, the People's Republic of China. Lansen Pharmaceutical Holdings Limited is a subsidiary of Cathay International Pharma Manufacture and Distribution (China) Limited.
Home Page: www.lansen.com.cn
228 Xinfeng Road
Ningbo,
315174
China
Phone:
86 574 8804 6316
Officers
| Name | Title |
|---|---|
| Mr. Li Chen | Exec. MD, CEO & Exec. Director |
| Mr. Kai Fai Pang | Fin. Mang. & Company Sec. |
| Mr. Yu Zhao | Group HR Director |
| Mr. Jianshe Nan | Head of Bus. Devel. |
| Mr. Hua Li | Head of Fin. Management Centre |
| Mr. Dezhong Yao | Head of the Group's production & Operation Management Centre |
Exchange: HK
Country: HK : Hong Kong
Currency: Hong Kong Dollar (HK$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 12.4167 |
| Price-to-Book MRQ: | 0.6186 |
| Price-to-Sales TTM: | 9.6515 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 621 |